For athletes and active patients, the arrival of oral GLP-1 options opens new possibilities
GLP-1RAs demonstrate anti-inflammatory properties both systemically and within the TME (for example, by modulating macrophages and T cells, and reducing NETs as described in the present review), thereby suppressing the pro-tumor inflammatory milieu (105,108-110,121)
If you decide to optimize both site and timing, keep the time consistent even as you rotate sites
All forms work through the same mechanism, but how they get into your system differs significantlyand this matters more than you might think
Overall, we identified 280 pre-clinical and mechanistic studies (Fig
Furthermore, candidates for GLP-1 may include: Individuals with obesity who have a body mass index (BMI) of 30 or higher or who have a BMI of 27 or higher and also have at least one weight-related health condition, such as type 2 diabetes or high blood pressure